Abstract
Thirteen patients with chronic intraocular inflammation which had not been adequately controlled with oral prednisolone entered into an open study of low-dose Cyclosporin A (mean 4.1 mg/kg/day) combined when required with oral prednisolone (15 mg prednisolone per day or less). The mean duration of treatment was 26 months (range 8-44) over a mean follow-up period of 29 months (range 8-49). Visual acuity improved overall in ten patients, and remained stable in three. Six patients have completed a course of Cyclosporin A therapy, and four of these patients have retained their visual improvement. Two have returned to the pretreatment level of vision. Only one patient has required conversion to alternative immunosuppressive therapy. The mean serum creatinine concentration had increased significantly by 26% after six months (p<0.05) and 32% after one year (p<0.01) but remained stable during the subsequent 18 months. Four patients developed hypertension requiring hypotensive therapy. On cessation of CsA treatment, the mean serum creatinine concentration fell to the upper reference limit. The elevation of serum creatinine concentration was significantly higher in patients who either developed hypertension during Cyclosporin A therapy or who were previously known to be hypertensive. Patients with nephrotoxicity were significantly older than those in whom serum creatinine concentration remained within the reference range. Lithium clearance studies showed evidence of proximal renal tubular dysfunction which was partially reversible on dose reduction or withdrawal.
Similar content being viewed by others
Article PDF
References
Forrester JV : Chronic Intraocular Inflammation. Trans Ophthalmol Soc UK 1985, 104: 250–5.
Department of Health and Social Security: Blindness and partial sight in England 1969-1976. London: HMSO, 1979. (Reports on Public Health and Medical Subjects No. 129.)
Nussenblatt RB, Palestine AG, Rook AH, et al.: Treatment of intraocular inflammatory disease with Cyclosporin A. Lancet 1983, ii: 235–38.
Nussenblatt RB, Rodrigues MM, Walker WB, et al.: Cyclosporin A. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest 1981, 67: 1228–31.
Nussenblatt RB, Palestine AG, Chan CC : Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 1983, 96: 275–82.
Binder AI, Graham EM, Sanders MD, Dinning W, James DG, Denman AM : Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol 1987, 26: 285–91.
Muftuoglu AU, Pazarli H, Yurdakul S, et al: Short term cyclosporin A treatment of Behçet's disease. Br J Ophthalmol 1987, 71: 387–90.
Masuda K, Nakajima A, Urayama A, et al.: Double-masked trial of Cyclosporin versus Colchicine and long-term study of Cyclosporin in Behçet's Disease. Lancet 1989, i: 1093–6.
Palestine AG, Nusenblatt RB, Chan CC : Side effects of systemic cyclosporin in patients not undergoing transplantation. Am J Med 1984, 77: 652–6.
Palestine AG, Austin HA, Balow JE, et al: Renal histopathological alterations in patients treated with cyclosporine for uveitis. N Eng J Med 1986, 314: 1293–8.
Klintmalm G, Bohman S, Sundelin B, Wilczek, H : Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effects of low doses in early post-transplantation period. Lancet 1984, ii: 950–4.
Svenson K, Bohman S-O, Hallgren R : Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with Cyclosporine. Arch Int Med 1986, 146: 2007–10.
Starzl TE, Nalesnik NA, Porter KE, et al.: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984, ii: 583–7.
Towler HM, Cliffe AM, Whiting PH, Forrester JV : Low dose Cyclosporin A therapy in chronic posterior uveitis. Eye 1989, 3: 282–7.
Nussenblatt RB, Palestine AG, Chan CC, Roberge F : Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985, 92: 467–71.
Thomsen K : Lithium clearance: a new method for determining proximal and distal tubular resorption of sodium and water. Nephron 1984, 37: 217–23.
Palestine AG, Austin AA, Nussenblatt RB : Renal tubular function in Cyclosporine-treated patients. Am J Med 1986, 81: 419–24.
Deray G, Le Hoang P, Cacoub P, et al.: Renal function and blood pressure in patients treated with Cyclosporin A for uveitis. Eur J Clin Pharmacol 1988, 34: 601–4.
Hamilton DV, Carmichael DJS, Evans DB, Calne RY : Hypertension in renal transplant recipients on Cyclosporin A and corticosteroids and azathioprine. Transpl Proc 1982, 14: 597–600.
Chapman JR, Marcen R, Arias M, et al.: Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression. Transplantation 1987, 43: 860–4.
Leading Article: Cyclosporin hypertension. Lancet 1988, ii: 1234.
Kahaly G, Schrezenmeir J, Krause U, et al.: Cyclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomised and prospective study. Eur J Clin Invest 1986, 16: 415–22.
McNally PG, Feehally J, Walls J : Nifedipine increases GFR in chronic Cyclosporin-treated renal transplant recipients. Nephr Dialysis transpl 1989, 4: 515 (abstract).
Propper DJ, Whiting PH, Power DA, et al.: The effect of nifedipine on graft function in renal allograft recipients treated with Cyclosporin A Clin Nephrol (in press).
Author information
Authors and Affiliations
Additional information
Presented at the Oxford Ophthalmological Congress, July 1989.
Rights and permissions
About this article
Cite this article
Towler, H., Whiting, P. & Forrester, J. Combination low dose Cyclosporin a and steroid therapy in chronic intraocular inflammation. Eye 4, 514–520 (1990). https://doi.org/10.1038/eye.1990.68
Issue Date:
DOI: https://doi.org/10.1038/eye.1990.68
This article is cited by
-
Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-a-treated lewis rats: Future treatment of endogenous posterior uveoretinitis?
Eye (1997)
-
The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis
Eye (1994)
-
Immunomodulation of experimental autoimmune uveoretinitis: A model of tolerance induction with retinal antigens
Eye (1994)
-
Pars planitis in a family
International Ophthalmology (1994)
-
Sympathetic ophthalmia: Visual results with modern immunosuppressive therapy
Eye (1992)